Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 -- "Aberrant DNA methylation is a recognized feature of human cancers, and folate is directly involved in DNA methylation via one-carbon metabolism. Previous reports also suggest that folate status is associated with the natural history of human......
2009 NOV 23 -- A report, 'Human papilloma viruses and cancer in the post-vaccine era,' is newly published data in Clinical Microbiology and Infection. "Human papilloma viruses (HPV) are strong human carcinogens, in fact today they are considered as the......
2009 NOV 29 -- Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis. Published in this......
2009 NOV 23 -- The FDA will be held accountable during oral arguments Dec. 11 in federal court for its "inappropriate classification of a virus DNA-replicating device as a cancer test." The misclassification costs women extra worry and society at least $10......
2009 NOV 23 -- "Several different families of DNA viruses encode proteins that inactivate the cellular retinoblastoma tumor suppressor protein (pRb), which normally functions to bind E2F transcription factors and restrict expression of genes necessary for......
2009 NOV 29 -- DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of the National Cancer Institute. Cytology triage in......
2009 NOV 23 -- "Host factors are critical in regulating tumor growth, and cytokines that modulate immunological control may be of importance in cervical cancer. To study this, the cytokines were measured in peripheral blood mononuclear cells in women with......
2009 NOV 23 -- According to recent research published in the journal Cancer Causes & Control, "Human papilloma virus (HPV) prevalence studies performed in different regions and population groups across Canada would inform public health decisions regarding......
2009 NOV 23 -- According to a study from Mexico, "Dehydroepiandrosterone (DHEA) has a protective role against epithelial-derived carcinomas; however, the mechanisms remain unknown. We determined the effect of DHEA on cell proliferation, the cell cycle and cell......
2009 NOV 23 -- "p53 gene plays a crucial role in the response to therapy. Since it is inactivated in the majority of human cancers, it is strongly believed that the p53 mutations confer resistance to therapeutics," scientists in Zagreb, Croatia report.......
2009 NOV 23 -- Current study results from the report, 'Laryngeal squamous cell carcinoma in HIV-positive patients: lack of association with human papillomavirus infection,' have been published. "Neoplasms associated with human papillomavirus (HPV) infection......
2009 NOV 23 -- New research, 'Supraclavicular lymph node metastases of unknown origin: HPV-typing identifies the primary tumour,' is the subject of a report. According to a study from Kiel, Germany, "Cancers of unknown primary origin (CUP) account for......
2009 NOV 23 -- According to a study from Hefei, People's Republic of China, "Cervical cancer is the most common malignant disease responsible for the deaths of a large number of women in the developing world. Although certain strains of human papillomavirus......
2009 NOV 23 -- "Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through 3 years. We provide an update on the efficacy of the quadrivalent HPV vaccine against......
2009 NOV 23 -- According to recent research published in the Journal of Cancer Research and Clinical Oncology, "Praneem', a polyherbal formulation developed by us, has successfully completed Phase II efficacy study for treatment of abnormal vaginal discharge......
2009 NOV 23 -- Xenomics, Inc. (XNOM.PK), a developer of transrenal molecular diagnostics, announced that it has filed a patent application on novel technology for the detection of Human Papilloma Virus (HPV) DNA, based on Xenomics transrenal DNA technology. The......
